Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics

NCT00308685 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Albuterol
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.